Protirelin stimulation test and thyroid function during treatment of depression

Area of Science:

• Endocrinology
• Psychiatry
• Neuroscience

Background:

• Endogenous depression is a severe form of mood disorder.
• Thyroid hormone levels can be altered in psychiatric conditions.
• Electroconvulsive treatment (ECT) is an effective therapy for severe depression.

Purpose of the Study:

• To investigate thyroid hormone levels in patients with endogenous depression.
• To assess the impact of electroconvulsive treatment (ECT) on thyroid function.
• To explore the relationship between thyroid function, depression recovery, and relapse.

Main Methods:

• Serum thyroxine (T4), free T4 index, triiodothyronine (T3), free T3 index, and thyrotropin (TSH) levels were measured in 15 patients with endogenous depression.
• TSH response to protirelin (thyrotropin-releasing hormone) was assessed before and after ECT.
• Thyroid hormone levels and TSH response were correlated with depression recovery and relapse rates.

Main Results:

• Elevated serum T4 and free T4 index were observed before ECT (P < .02), normalizing after recovery.
• Serum T3 and free T3 index remained normal throughout the study.
• Diminished TSH response to protirelin was noted in depressed patients, normalizing after recovery. A blunted TSH response post-ECT was associated with higher relapse rates.

Conclusions:

• Thyroid function, particularly T4 levels and TSH response to protirelin, is altered in endogenous depression.
• ECT normalizes these thyroid disturbances, correlating with clinical recovery.
• The protirelin test may serve as a predictor of relapse in depression.